DAPIRING

This brand name is authorized in South Africa.

Active ingredients

The drug DAPIRING contains one active pharmaceutical ingredient (API):

`1`	Dapivirine UNII `TCN4MG2VXS` - DAPIVIRINE
	Dapivirine is an NNRTI with potent antiviral activity against HIV-1. It prevents viral replication by binding directly to HIV-1 reverse transcriptase (RT) and blocking its activity. Dapivirine binding is non-competitive against both the RNA template and the nucleotide substrate.
	Read more about Dapivirine

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
DAPIRING Vaginal delivery system	MPI, Generic	Health Products Regulatory Authority (ZA)

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
ZA	Health Products Regulatory Authority	55/20.2.8/0786

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.